KMPH - KemPharm GAAP EPS of -$0.05 beats by $0.01 revenue of $4M beats by $0.94M
KemPharm press release (NASDAQ:KMPH): Q1 GAAP EPS of -$0.05 beats by $0.01. Revenue of $4M beats by $0.94M. Total cash, cash equivalents, marketable securities and long-term investments was $119.1 million as of March 31, 2022
For further details see:
KemPharm GAAP EPS of -$0.05 beats by $0.01, revenue of $4M beats by $0.94M